Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Vesely Paul |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Nguyen, KL; Zauner, A; Taschler, U; Kolb, D; Höfler, G; Steinmetz, I; Vesely, P; Lichtenegger, S Lipid metabolism modulation in melioidosis: Investigating the impact of lipases on bacterial clearance and inflammation
"DocDay" of the doctoral schools "Molecular Biology and Biochemistry", University of Graz; JUL 01,2024; Graz, AUSTRIA. 2024. [Poster]

 

Vesely, PW; Thanh, HPT; Kanti, M; Subramaniyan, B; Moore, A; Georgescu, C; Wren, JD; Freeman, WM; Syarif, AH; Schauer, S; Schweiger, M; Kwapiszewska, G; Hoefler, G; Walters, MS; Marsh, LM Lipid-signaling as a Potential New Therapeutic Target in Chronic Obstructive Pulmonary Disease
AM J RESP CRIT CARE. 2024; 209: -ATS International Conference; MAY 17-22, 2024; San Diego, USA. [Oral Communication]
Web of Science

 

Wojcik, G; Sahu-Osen, A; Gindlhuber, J; Hutami Syarif, A; Birnhuber, A; Hoffmann, J; Mischkulnig, L; Bonyadi Rad, E; Wygrecka, M; Hoetzenecker, K; Evermann, M; Olschewski, A; Kersten, S; Bellusci, S; Marsh, L; Agha, E; Vesely, P; Kwapiszewska, G; Biasin, V COLLAGEN VS LIPIDS: THE LUNG FIBROSIS STORY.
22nd International Colloquium on Lung and Airway Fibrosis, ICLAF 2024,; OCT 12-16, 2024; Athens, GREECE. 2024. [Poster] [Science to Public]

 

Wojcik, G; Sahu-Osen, A; Gindlhuber, J; Syarif, A; Hoetzenecker, K; Bohm, P; Vesely, P; Kwapiszewska, G; Biasin, V Relationships between lipids and collagens in lung fibrosis
9th International Graz Symposium on Lipid and Membrane Biology; April 18-20, 2024; Graz. 2024. [Poster]
FullText

 

Wojcik, G; Sahu-Osen, A; Gindlhuber, J; Syarif, A; Wygrecka, M; Hoffman, J; Kersten, S; Mischkuling, L; Bonyadirad, E; Vesely, P; Crnkovic, S; Olschewski, A; Hoetzenecker, K; Bohm, P; Bellusci, S; March, LM; El Agha, E; Kwapiszewska, G; Biasin, V Exploring the role of Lipids in lung fibrosis: Understanding the complexities
DocDay 2024; Feb 8, 2024; Graz, AUSTRIA. 2024. [Poster]
FullText

 

Biasin, V; Osen, AS; Wojcik, G; Gindlhuber, J; Syarif, AH; Hoetzenecker, K; Böhm, P; Vesely, P; Bellusci, S; Marsh, LM; El Agha, E; Kwapiszewska, G Lipids: are they able to alter lung fibrosis?
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(19-20):580-580.-47. Jahrestagung der ÖGP - 7. Jahrestagung der ÖGTC; OCT 23-25, 2023; Graz, Austria. [Poster]
Web of Science

 

Wojcik,G; Sahu-Osen, A; Gindlhuber, J; Syarif, A; Wygrecka, M; Birnhuber, A; Hoffmann, J; Mischkulnig, L; Bonyadirad, E; Kersten, S; Hoetzenecker, K; Bohm, P; Olschewski, A; Vesely, P; Crnkovic, S; Bellusci, S; Marsh, LM; El Agha, E; Kwapiszewska, G; Biasin, V Lipids Unveiled: Exploring their Role in Pulmonary Fibrosis
The progression of Idiopathic Pulmonary Fibrosis (IPF) relies heavily on the overproduction of collagen and alterations in fatty acid (FA) metabolism. We propose that changes in lipid metabolism, driven by the actions of Angiopoietin-like 4 (ANGPTL4), may also have a significant impact on the activity of lung fibroblasts (PDGFRα+ cells), ultimately affecting the progression of lung fibrosis. . 2023; -7TH LUNG DAYS - 7. GRAZER LUNGENTAGE; NOV 23-24, 2023; Graz, AUSTRIA. [Poster]

 

Kanti, M; Strießnig-Bina, I; Wieser, I; Schauer, S; Kufferath, I; Schreiber, R; Kwapiszewska, G; Marsh, L; Gungl, A; Leitinger, G; Zechner, R; Vesely, PW; Hoefler, G Adipose triglyceride Lipase is needed for normal bronchiolar club cell metabolism
Doctoral Day, 2021; Public Presentations for Doc School and PhD Students; FEB 12, 2021; Graz, Austria. 2021. [Oral Communication]
FullText

 

Manu Manjunath Kanti, AIsabelle Striessnig-Bina, Beatrix Irene Wieser, Silvia Schauer, Gerd Leitinger, Thomas O. Eichmann, Martina Schweiger, Margit Winkler, Elke Winter, Andrea Lana, Iris Kufferath,1 Leigh Matthew Marsh, Grazyna Kwapiszewska, Rudolf Zechner, Gerald Hoefler, and Paul Willibald Vesely Adipose triglyceride lipase (ATGL) mediated substrate hydrolysis for Alveolar Type 2 pneumocyte function
DK-MCD: 11th Scientific Retreat; SEP 27-29, 2021; Schloss Seggau, Leibnitz, Austria. 2021. [Poster]

 

Kanti, M; Strießnig-Bina, I; Wieser, BI; Schauer, S; Kufferath, I; Schreiber, R, Marsh, L; Gungl, A; Kenner, L; Leitinger, G; Zechner, R; Hoefler, G; Vesely, PW Adipose triglyceride Lipase is needed for normal bronchiolar club cell metabolism.
12th ÖGMBT online meeting 2020.; OCT 6, 2021; Online, Vienna, Austria. 2020. [Onlinepräsentation]

 

Kanti, M; Strießnig-Bina, I; Wieser, BI; Schauer, S; Kufferath, I; Schreiber, R, Marsh, L; Gungl, A; Kenner, L; Leitinger, G; Zechner, R; Hoefler, G; Vesely, PW Adipose triglyceride Lipase is needed for normal bronchiolar club cell metabolism.
22nd EMBL PhD symposium, the roaring 20s- a new decade for life sciences; NOV 27-28, 2020; EMBL Heidelberg, Germany. 2020. [Onlinepräsentation]
FullText

 

Kanti, M; Strießnig-Bina, I; Wieser, BI; Schauer, S; Kufferath, I; Schreiber, R; Marsh, L; Gungl, A; Kenner, L; Leitinger, G; Zechner, R; Hoefler, G; Vesely, PW Adipose triglyceride Lipase is needed for normal bronchiolar club cell metabolism.
DK-MCD scientific retreat; SEP 28-29, 2020 ; Graz, Austria. 2020. [Oral Communication]

 

Beatrix I. Wieser, Silvia Schauer, Peter Hofer, Martina Schweiger, Isabelle Strießnig-Bina, Guenter Haemmerle, Rudolf Zechner, Gerald Hoefler and Paul W. Vesely Regulation of Sterol Regulatory Element-Binding Protein-1 (SREBP-1) by lipolysis products from Adipose Triglyceride Lipase (ATGL)
Organ crosstalk in energy balance and metabolic disease; Apr 8-11, 2019; Cadiz. 2019. [Poster]
FullText

 

Kanti, M; Strießnig-Bina, I; Wieser, BI; Schauer, S; Kufferath, I; Schreiber, R; Marsh, L; Gungl, A; Kenner, L; Leitinger, G; Zechner, R; Hoefler, G; Vesely, PW ’Adipose triglyceride Lipase is needed for normal bronchiolar club cell metabolism
DK-MCD scientific retreat; JAN 20-21, 2020; Leibnitz, Austria. 2019. [Oral Communication]

 

Beatrix I. Wieser; Silvia Schauer; Isabelle Strießnig-Bina; Martina Schweiger; Rudolf Zechner; Paul W. Vesely; Gerald Höfler; Regulation of Sterol Regulatory Element Binding Protein (SREBP)-1 through Adipose TriGlyceride Lipase (ATGL)
DocDay; 28.11.2018; Graz. 2018. [Poster]

 

Wieser, BI; Strießnig-Bina, I; Schauer, S; Schweiger, M; Zechner, R; Höfler, G; Vesely, PW Regulation of Sterol Regulatory Element Binding Proteins (SREBPs) by Lipolysis Products
Lipotoxicity: Lipid-induced Cell Dysfunction and Cell Death; 09.04.2018-11.04.2018; Graz. 2018. [Poster]

 

Bina, I., Al-Zoughbi, W., Schauer, S., Stadelmeyer, E., Nicholson Puthen Veedu, S., Lana, A., Marsh, L., Schlederer, M., Schweiger, M., Casanova, E., Kenner, L., Zechner, R.(2), Hoefler, G.(1) and Vesely, P.W.(1,2) ATGL deficiency leads to lung cancer in mice
Tumor Metabolism: Mechanisms and Targets (X3); MARCH 5-9, 2017; Whistler. 2017. [Poster]

 

Bina, I., Al-Zoughbi, W., Schauer, S., Wieser, B., Stadelmeyer, E., Nicholson Puthen Veedu, S., Lana, A., Marsh, L., Schlederer, M., Schweiger, M., Casanova, E., Kenner, L., Zechner, R., Hoefler, G. and Vesely, P.W. ATGL deficiency leads to lung cancer in mice
Doctoral Day 2017 (MedUniGraz); DEZ 13,2017; Graz. 2017. [Oral Communication]

 

S. Nicholson Puthen Veedu1, C. Madreiter-Sokolowski3, D. Hofer4, I. Bina1, E. Stadelmeyer1 S. Schauer1, R. Zechner2, J. Bogner-Strauss4, W. Graier3, G. Hoefler1, and P. W. Vesely1, 2 Tracing metabolic evolution: From normal to immortalization
Keystone symposium tumor metabolism; march 5-9; Whistler Canada. 2017. [Poster]

 

Wieser, B; Kein, B; Schauer, S; Bina, I; Stadelmeyer, E; Nicholson Puthen, VS; Schweiger, M; Zechner, R; Höfler, G; Vesely, PW Regulation of Sterol Regulated Element Binding Proteins by Lipolysis Products
DocDay Medical University of Graz; December 13, 2017; Graz. 2017. [Poster]

 

Wieser, B; Schauer, S; Stadelmeyer, E; Bina, I; Nicholson Puthen, VS; Schweiger, M; Zechner, R; Höfler, G; Vesely, P. Lipolysis in cancer
Keystone Symposia on Molecular and Cellular Biology; März 5-9, 2017; Whistler, Canada. 2017. [Poster]

 

Bina, I., Al-Zoughbi, W., Schauer, S., Stadelmeyer, E., Nicholson Puthen Veedu, S., Lana, A., Marsh, L., Schlederer, M., Schweiger, M., Casanova, E., Kenner, L., Zechner, R., Hoefler, G. and Vesely, P.W. ATGL deficiency leads to lung cancer in mice
YSA PhD Symposium 2016; 2016. [Poster]

 

Bina, I., Al-Zoughbi, W., Schauer, S., Stadelmeyer, E., Nicholson Puthen Veedu, S., Lana, A., Marsh, L., Schlederer, M., Schweiger, M., Casanova, E., Kenner, L., Zechner, R., Hoefler, G. and Vesely, P.W. ATGL deficiency leads to lung cancer in mice
6th International Graz Symposium on Lipid and Membrane Biology; 2016. [Oral Communication]

 

Bina, I., Al-Zoughbi, W., Schauer, S., Stadelmeyer, E., Nicholson Puthen Veedu, S., Lana, A., Marsh, L., Schlederer, M., Schweiger, M., Casanova, E., Kenner, L., Zechner, R., Hoefler, G. and Vesely, P.W. ATGL deficiency leads to lung cancer in mice
Doctoral Day 2016; 2016. [Oral Communication]

 

S. Nicholson Puthen Veedu, C. Madreiter-Sokolowski, D. Hofer, I. Bina, E. Stadelmeyer S. Schauer, R. Zechner, J. Bogner-Strauss, W. Graier, G. Hoefler, and P. W. Vesely. Tracing metabolic evolution: From normal to cancerous
Doctoral Day technical University; 2016. [Poster]

 

Bina, I; Stadelmeyer, E; Nicholson Puthen Veedu, S; Schauer, S; Al-Zoughbi, W; Schweiger,M; Yamada, S; Zechner, R; Hoefler, G; Vesely, P W; ATGL in tumor development and progression
Doctoral Day 2015 of the Medical University of Graz; 2015. [Poster]

 

Bina, I; Stadelmeyer, E; Nicholson Puthen Veedu, S; Schauer, S; Al-Zoughbi, W; Schweiger,M; Yamada, S; Zechner, R; Hoefler, G; Vesely, P W; ATGL in tumor development and progression
40th Symposium on Hormones and Cell Regulation; 2015. [Poster]

 

Nicholson Puthen Veedu, S; Stadelmeyer, E; Bina, I; Yamada, S; Schauer, S; Al-Zoughbi, W; Zechner, R; Hoefler, G and Vesely, PW Oncogene driven metabolic reprogramming
40th symposium of ESE. 2015; -40th symposium on Hormones and Cell Regulation of the European society of endocrinology ( ESE); OCT 8-11, 2015; Mount ste. Odile, France . [Poster]

 

Nicholson Puthen Veedu, S; Stadelmeyer, E; Bina, I, Yamada, S; Schauer, S; Al-Zoughbi, W; Zechner, R; Hoefler, G. and Vesely, PW Oncogene driven metabolic reprogramming
Abstract book . 2015; -Doctoral day 2015 ; DEC 11, 2015; Graz, Austria. [Poster]

 

Al-Zoughbi, W; Tamilarasan, KP; Das, SK; Vesely, PW; Schauer, S; Guertl-Lackner, B; Haemmerle, G; Zechner, R; Sexl, V; Hoefler, G; ATGL downregulation enhances tumor growth suggesting a function as metabolic tumor suppressor protein.
Tumor Metabolism meets Immunology; APR 25- 27, 2013; Regensburg, Bavaria, Germany. 2013. [Oral Communication]
FullText

 

Huang, J;Al Zoughbi, W; Shanmugam, G; Vesely, P; Birner-Gruenberger, R; Kratky, D; Hoefler, G Reprogramming of hepatic lipid metabolism in tumor-associated cachexia and its potential influ-ence on tumor growth
MUG Doc Day; DEC 9, 2013; Graz, AUSTRIA. 2013. [Poster]

 

Al Zoughbi, W; Tamilarasan, KP; Das, SK; Vesely, PW; Schauer, S; Gürtl-Lackner, B; Zechner, R; Hoefler, G; Adaption of Lipid Metabolism in Cancer Cells under Hypoxic Conditions
Abstract book. 2012; -KeyStonesymposia Cancer and Metabolism conference; 12-17 February, 2012; Banff, Canada. [Poster]

 

Al Zoughbi, W; Tamilarasan, KP; Das, SK; Vesely, PW; Schauer, S; Gürtl-Lackner, B; Hämmerle, G; Zechner, R; Sexl, V; Hoefler, G Downregulation of ATGL enhances malignant tumors growth, ATGL as a Tumor Suppressor Protein
Abstract Book. 2011; -KeyStonesymposia Cancer Control by Tumor Suppressors and Immune Effectors ; 12-17 February, 2011; Santa Fe, USA. [Poster]

 

Al Zoughbi, W; Tamilarasan, KP; Das, SK; Vesely, PW; Schauer, S; Gürtl-Lackner, B; Hämmerle, G; Zechner, R; Sexl, V; Hoefler, G Downregulation of ATGL enhances malignant tumors growth, ATGL as a Tumor Suppressor Protein
Abstract book. 2011; -KeyStonesymposia Cancer Control by Tumor Suppressors and Immune Effectors; 12-17 February, 2011 ; Santa Fe, USA. [Oral Communication]

 

Das, SK; Schauer, S; Eder, S; Diwoky, C; Temmel, H; Guertl, B; Gorkiewicz, G; Tamilarasan, KP; Kumari, P; Trauner, M; Zimmermann, R; Vesely, P; Haemmerle, G; Zechner, R; Hoefler, G. ROLE OF LIPASES IN CANCER-ASSOCIATED CACHEXIA
6th Cachexia Conference; DEC 8-10, 2011; Milan, Italy. 2011. [Poster]
FullText

 

Kenner, L; Laimer, D; Dolznig, H; Vesely, P; Kollmann, K; Schiefer, AII; Sexl, V; Staber, PB; Hoefler, G; Penninger, J; Inghirami, G; Ulrich, J New and Highly Efficient Therapy for Treatment NPM-ALK Associated Lymphomas
BLOOD. 2011; 118(21): 721-721.
Web of Science

 

Al-Zoughbi, W; Das, S; Schauer, S; Gorkiewicz, G; Palaniappan, TK; Guertl-Lackner, B; Vesely, P; Hoefler, G. Expression of ATGL is up regulated in malignant tumour cells under hypoxic condition.
Pannonia Congress of Pathology; MAR 3 - 6, 2010; Graz, AUSTRIA. 2010. [Poster]

 

Das SK.; Vesely PW.; Schauer S.; Schittmayer M.; Schwarz A.; Claudel T.,Birner-Grünberger R.; Zechner R.; Höfler G. miR-124a: MasterRegulator of Lipolysis and ß-oxidation.
3rd InternationalGraz symposium on lipid and membrane biology; 18-20 March, 2010; Graz, Austria. 2010. [Oral Communication]

 

Senanayake, U; Das, S; Leuscher, I; Schauer, S; Vesely, P; Hoefler, G; Guertl, B Six2 stem cell regulator and oncogene?
Intercongress Meeting of the European Society of Pathology; AUG 31 - SEPT 3, 2010; Krakau, POLAND. 2010. [Oral Communication]

 

Senanayake, U; Das, S; Leuscher, I; Schauer, S; Vesely, P; Hoefler, G; Guertl, B. Six2 stem cell regulator and oncogene?
Doctoral and ZMF Day Medical University of Graz; NOV 5-6; Graz, Austria. 2010. [Oral Communication]

 

Senanayake, U; Das, S; Leuschner, I; Schauer, S; Vesely, P; Höfler, G; Gürtl, B Six 2 stem cell regulator and oncogene?
Intercongress Meeting of the European Society of Pathology; Aug 31-Sep3, 2010; Krakau. 2010. [Oral Communication]

 

Senanayake, U; Das, S; Schauer, S; Vesely, P, Hoefler, G; Guertl, B Six2 - embryonically active transcription factor with oncogenic properties
Pannonia Congress of Pathology; MARCH 3-6, 2010; Graz, AUSTRIA. 2010. [Poster]

 

Tamilarasan, KP; Al-Zoughbi, W; Das, SK; Vesely PW, Schauer, S; Hämmerle, G; Zechner, R; Sexl, V; Hoefler G, Importance of ATGL in Tumour Progresseion.
3rd International Graz Symposium on Lipid and Membrane Biology; MAR 18 - 20, 2010; Graz, AUSTRIA. 2010. [Poster]

 

Das SK.; Vesely PW.; Schauer S.; Haemmerle G.; Eder S.; Zimmermann R.; Tamilarasan KP.; ZechnerR.; Höfler G Cancer associated cachexia is mediated by ATGL
Gordon Conference on “Molecular and Cellular Biology of Lipids”2009; -Gordon Conference on “Molecular and Cellular Biology of Lipids”; July 19-24, 2009; Watervilley Valley, NH, USA. [Poster]

 

Das SK.;Vesely PW.; Schauer S.; Zechner R.; Höfler G. miR-124a regulates lipolysis
34th FEBS congress.2009; -34th FEBS congress.; July 4-9, 2009; Prague, Czech Republic. [Poster]

 

Moustafa, T; Fickert, P; Magnes, CH; Halilbasic, E; Fuchsbichler, A; Sinner, F; Fauler, G; Vesely, P; Frank, S; Kratky, D; Gumhold, J; Silbert, D; Denk, H; Guelli, CH; Trauner, M 24-norursodeoxycholic acid, a side-chain modified bile acid targets inflammation, oxidative stress and lipid metabolism in chronic liver injury.
keine2009; -ZMF & Doctoral Day; Nov, 2009; Graz, AUSTRIA. [Poster]

 

Moustafa, T; Fickert, P; Fuchsbichler, A; Fauler, G; Streith, I; Vesely, P; Silbert, D; Gumhold, J; Denk, H; Trauner, M Side-chain modification of Ursodeoxycholic acid alters cellular hyper-proliferation and lipid homeostasis in a mouse model of chronic cholestatic liver injury.
keine2008; -ZMF Day; NOV, 2008; Graz, AUSTRIA. [Oral Communication]

 

Fuchs, C; Vesely, P; Bambach, I; Schauer, S; Linkesch, W; Stemberg, DW; Hoefler, G; Staber, PB Identification of critical phosporylation sites within NPM-ALK that regulate JUNB mRNA translation
BLOOD. 2007; 110(11):1044A-1045A.-49 th Annual Meeting of the American Society of Hematology; NOV 8-11, 2007; Atlanta, Georgia, USA. [Poster]
Web of Science

 

Laimer, D; Vesely, P; Staber, P; Pflegerl, P; Brandes, R; Schlederer, M; Hoefler, G; Kenner, L Role of junb in ALCL lymphoma development
HAEMATOL-HEMATOL J. 2007; 92: 344-344.Vienna. [Poster]
Web of Science

 

Moustafa, T; Fickert, P; Vesely, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Denk, H; Guelly, C; Trauner, M Retention of toxic bile acids activate the mTOR, p70S6k/rps6 signaling pathway in mouse models of cholestatic liver injury
J HEPATOL. 2007; 46: S23-S23. Doi: 10.1016/S0168-8278(07)61646-8 [Oral Communication]
Web of Science FullText FullText_MUG

 

Staber, P; Vesely, P; Fuchs, C; Bambach, I; Schauer, S; Bergler, H; Sternberg, D; Hoefler, G The oncoprotein NPM-ALK induces translation of AP-1 factors via mTOR signalling
HAEMATOL-HEMATOL J. 2007; 92: 344-344.Vienna. [Oral Communication]
Web of Science

 

Staber, PB; Vesely, P; Fuchs, C; Schauer, S; Sternberg, DW; Hoefler, G NPM-ALK induces JUNB and converts its role from a tumor suppressor to an oncogene
FEBS J. 2007; 274: 150-150. [Poster]
Web of Science

 

Staber PB; Vesely P; Sternberg W; Ott, RG; Kadin, ME; Linkesch, W; Schauer, S; Sexl, V; Kenner, L; Hoefler, G NPM-ALK fusion tyrosine kinase of anaplastic large cell lymphoma promotes neoplasia by inducing JunB via ERK1/2 and mTOR signalling
Wiener Medizinische Wochenschrift2007; 157(121):5-5.-Frühjahrestagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2007; Wien. [Oral Communication]

 

Vesely, P; Staber, P; Fuchs, C; Bambach, I; Schauer, S; Sternberg, D; Kenner, L; Hoefler, G Expression of NPM-ALK leads to oncogenic effects of JunB
HAEMATOL-HEMATOL J. 2007; 92: 107-107.Vienna. [Oral Communication]
Web of Science

 

Vesely, P; Staber, PB; Fuchs, C; Schauer, S; Bergler, H; Sternberg, DW; Hoefler, G Translational control of JUNB via the fusion tyrosine kinase NPM-ALK in ALC(L) lymphoma
FEBS J. 2007; 274: 150-150. [Poster]
Web of Science

 

Moustafa, T; Fickert, P; Fuchsbichler, A; Vesely, P; Silbert, D; Gumhold, J; Denk, H; Guelly, CH; Trauner, M he side-chain shortened bile acid 24-norUDCA reverses biliary fibrosis and alters cellular hyperproliferation in a mouse model of chronic cholestatic liver injury.
keine2006; -ZMF Day; NOV, 2006; Graz, AUSTRIA. [Oral Communication]

 

Staber, PB; Vesely, P; Ott, R; Haq, N; Linkesch, W; Schauer, S; Hrzenjak, A; Kenner, L; Dirks, W; Kadin, ME; Sternberg, DW; Hoefler, G NPM-ALK fusion tyrosine kinase of anaplastic large cell lymphoma exerts its transforming potential by increasing translation of JUNB through mTOR and S6K1.
BLOOD. 2006; 108(11): 414A-415A. Doi: 10.1182/blood.V108.11.1428.1428 [Poster]
Web of Science FullText FullText_MUG

 

Vesely, P; Staber, PB; Ott, R; Pinent, M; Linkesch, W; Schauer, S; Hrzenjak, A; Kadin, ME; Sternberg, DW; Hoefler, G NPM-ALK converts JUNB from a tumor suppressor to an oncogene.
BLOOD. 2006; 108(11): 419A-420A. Doi: 10.1182/blood.V108.11.1448.1448 [Poster]
Web of Science FullText FullText_MUG

 

Staber, PB; Vesely, P; Ott, R; Schauer, S; Linkesch, W; Kadin, ME; Dirks, W; Sternberg, DW; Höfler, G; NPM-ALK fusion kinase actiivates AP-1-DNA binding via junB.
Wien Med Wscr. 2005; 155(117):19-19. [Poster]

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum